This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Garces, C. A. Articles by Cance, W. G. Search for Related Content PubMed PubMed Citation Articles by Garces, C. A. Articles by Cance, W. G.

Vascular Endothelial Growth Factor Receptor-3 and Focal Adhesion Kinase Bind and Suppress Apoptosis in Breast Cancer Cells

Departments of Surgery, Biochemistry, and Molecular Biology, University of Florida, Gainesville, Florida

Requests for reprints: William G. Cance, Department of Surgery, University of Florida, P.O. Box 100286, 1600 Southwest Archer Road, Gainesville, FL 32610. Phone: 352-265-0622; Fax: 352-338-9809; E-mail: cance{at}surgery.ufl.edu.

Focal adhesion kinase (FAK) and vascular endothelial growth factor receptor-3 (VEGFR-3) are protein tyrosine kinases that are overexpressed in human cancer and play an important role in survival signaling. In addition to its involvement with cell survival, VEGFR-3 is a primary factor in lymphatic angiogenesis. Because FAK function is regulated by its COOH terminus (FAK-CD), we used FAK-CD as a target to identify binding partners. We isolated a peptide from a phage library that bound to FAK-CD, specifically the focal adhesion targeting domain of FAK and was homologous to VEGFR-3, suggesting these two tyrosine kinases physically interact. We have also shown that VEGFR-3 is overexpressed in human breast tumors and cancer cell lines. For the first time, we have shown the physical association of FAK and VEGFR-3. The association between the NH₂ terminus of VEGFR-3, containing the peptide identified by phage display, and the COOH terminus of FAK was detected by in vitro and in vivo binding studies. We then coupled a 12-amino-acid VEGFR-3 peptide, AV3, to a TAT cellular penetration sequence and showed that AV3 and not control-scrambled peptide caused specific displacement of FAK from the focal adhesions and affected colocalization of FAK and VEGFR-3. In addition, AV3 peptide decreased proliferation and caused cell detachment and apoptosis in breast cancer cell lines but not in normal breast cells. Thus, the FAK/VEGFR-3 interaction may have a potential use to develop novel molecular therapeutics to target the signaling between FAK and VEGFR-3 in human tumors. (Cancer Res 2006; 66(3): 1446-54)

This article has been cited by other articles:

				W. Liu, D. A. Bloom, W. G. Cance, E. V. Kurenova, V. M. Golubovskaya, and S. N. Hochwald FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells Carcinogenesis, June 1, 2008; 29(6): 1096 - 1107. [Abstract] [Full Text] [PDF]

				E. A. Beierle, N. A. Massoll, J. Hartwich, E. V. Kurenova, V. M. Golubovskaya, W. G. Cance, P. McGrady, and W. B. London Focal Adhesion Kinase Expression in Human Neuroblastoma: Immunohistochemical and Real-time PCR Analyses Clin. Cancer Res., June 1, 2008; 14(11): 3299 - 3305. [Abstract] [Full Text] [PDF]

				W. G. Cance and V. M. Golubovskaya Focal Adhesion Kinase Versus p53: Apoptosis or Survival? Sci. Signal., May 20, 2008; 1(20): pe22 - pe22. [Abstract] [Full Text] [PDF]

				X. Qin, Y. Wan, M. Li, X. Xue, S. Wu, C. Zhang, Y. You, W. Wang, C. Jiang, Y. Liu, et al. Identification of a Novel Peptide Ligand of Human Vascular Endothelia Growth Factor Receptor 3 for Targeted Tumour Diagnosis and Therapy J. Biochem., July 1, 2007; 142(1): 79 - 85. [Abstract] [Full Text] [PDF]

				J. A. Lunn, R. Jacamo, and E. Rozengurt Preferential Phosphorylation of Focal Adhesion Kinase Tyrosine 861 Is Critical for Mediating an Anti-apoptotic Response to Hyperosmotic Stress J. Biol. Chem., April 6, 2007; 282(14): 10370 - 10379. [Abstract] [Full Text] [PDF]

				P. Laakkonen, M. Waltari, T. Holopainen, T. Takahashi, B. Pytowski, P. Steiner, D. Hicklin, K. Persaud, J. R. Tonra, L. Witte, et al. Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth Cancer Res., January 15, 2007; 67(2): 593 - 599. [Abstract] [Full Text] [PDF]